共 18 条
[1]
Weber J(2007)Review: anti-CTLA-4 antibody ipilimumab: case studies of clinical response and immune-related adverse events Oncologist 12 864-872
[2]
Leach DR(1996)Enhancement of antitumor immunity by CTLA-4 blockade Science 271 1734-1736
[3]
Krummel MF(2005)CTLA-4 blockade: autoimmunity as treatment J Clin Oncol 23 8926-8928
[4]
Allison JP(2005)Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4 J Clin Oncol 23 6043-6053
[5]
Kapadia D(2007)Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade Clin Cancer Res 13 6681-6688
[6]
Fong L(2005)Antibody-mediated pure red cell aplasia (PRCA) treatment and re-treatment: Multiple options Nephrol Dial Transplant 20 iv23-iv26
[7]
Attia P(2005)Intravenous immunoglobulins in autoimmune- or parvovirus B19-mediated pure red-cell aplasia Autoimmun Rev 4 264-269
[8]
Phan GQ(undefined)undefined undefined undefined undefined-undefined
[9]
Maker AV(undefined)undefined undefined undefined undefined-undefined
[10]
Downey SG(undefined)undefined undefined undefined undefined-undefined